Clinical Trials
61 trialsTumor HI
Rezolute
EUSRFAINSU
Sahlgrenska University Hospital
Diagnosing and Treating Low Blood Sugar Levels
National Institutes of Health Clinical Center (CC)
DOTATOC PET/CT for Imaging NET Patients
British Columbia Cancer Agency
18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
Children's Hospital of Philadelphia
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
Eastern Cooperative Oncology Group
Clinical Study of 18F-Exendin-4 in Insulinoma
Sichuan Provincial People's Hospital
ERASIN-RCT
Azienda Ospedaliera Universitaria Integrata Verona
18FDOPA HI
Washington University School of Medicine
EURAGIL
Herlev Hospital
Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor
Rezolute
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
Tianjin Medical University
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Mayo Clinic
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
Cook Children's Health Care System
Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Stanford University
CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia
Barts & The London NHS Trust
A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic Duct
Peking Union Medical College Hospital
The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma
First Affiliated Hospital of Fujian Medical University
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
Eastern Cooperative Oncology Group
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
Eastern Cooperative Oncology Group
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
University of California, San Francisco
18F-FDOPA PET in Neuroendocrine Tumours
British Columbia Cancer Agency
177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs
British Columbia Cancer Agency
[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
Peking Union Medical College Hospital
LTW
Laser Tissue Welding, Inc.
Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
University of Southern California
GLP-1-AHH
Radboud University Medical Center
Pasireotide in Hyperinsulinemic Hypoglycemia
Montefiore Medical Center
Blinded Resection in Case of the Pancreatic Insulinoma
Vishnevsky Center of Surgery
Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer
National Cancer Institute (NCI)
Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
Nanjing First Hospital, Nanjing Medical University
Application of Raw Corn Starch on Patients With Insulinoma
Peking Union Medical College Hospital
Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy
Masonic Cancer Center, University of Minnesota
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
Vanderbilt-Ingram Cancer Center
Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors
Yale University
Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors
Academic and Community Cancer Research United
Cinacalcet to Treat Familial Primary Hyperparathyroidism
National Institutes of Health Clinical Center (CC)
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
Emory University
Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma
National Cancer Institute (NCI)
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
University of Iowa
Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery
Federation Francophone de Cancerologie Digestive
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
Eastern Cooperative Oncology Group
68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
Peking Union Medical College Hospital
Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
University Hospital, Basel, Switzerland
Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
National Cancer Institute (NCI)
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer
Yale University
EUS
Guangxi Medical University
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors
National Cancer Institute (NCI)
Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer
Delcath Systems Inc.